Found 41 matching trials
Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine PHASE3 The primary purpose of this study is to evaluate the persistence of bacteri...
Show More Location
Dr. Johannes Kandzora and Dr. Kathrin Kandzora
Learn More & Join Trial
A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents PHASE4 The main objective is to determine whether immune responses to Tdap (GlaxoS...
Show More Location
Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615
Learn More & Join Trial
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study N/A This safety surveillance study of GlaxoSmithKline's quadrivalent meningococ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years. PHASE3 The purpose of the study was to assess the immunogenicity and safety of two...
Show More Location
06 Kosin University Gospel Hospital 34, amnam-dong
Learn More & Join Trial
Safety Surveillance of MenACWY-CRM Vaccine in Children N/A The purpose of this study is to summarize the occurrence of incident seriou...
Show More Location
Kaiser Permanente South California
Learn More & Join Trial
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants PHASE2 The purpose of this study is to evaluate the safety, immunogenicity and ind...
Show More Location
Vaccine Evaluation Center
Treatments Being Tested
MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation) MenACWY Ad+ (MenACWY-CRM, adjuvanted formulation) MenACWY PS (MenACWY-CRM, polysaccharide vaccine) HBV (Hepatitis B vaccine) Prevnar (pneumococcal polysaccharide serotypes 4, 9V, 14, 18C, 19F, 23F & 6B conjugated to the CRM197) MMR (Measles, Mumps and Rubella vaccine) DTaPHibIPV (Diphtheria, Tetanus, acellular Pertussis, H. Influenzae type b, Inactivated Poliovaccine) Menjugate (Men C conjugated vaccine) Learn More & Join Trial
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan PHASE3 This study will evaluate the immunogenicity and safety of a single injectio...
Show More Location
Mackay Memorial Hospital,
Learn More & Join Trial
Safety of MenACWY-CRM Vaccination in Adolescents N/A The purpose of this US FDA post-marketing commitment study is to evaluate t...
Show More Location
Riverside Medical Center Campus, 10800 Magnolia Ave
Learn More & Join Trial
Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers PHASE2 Evaluate the immune response and reactogenicity of one dose of Meningococca...
Show More Location
Dipartimento di Prevenzione S C Igiene e Sanita Pubblica
Learn More & Join Trial
B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants PHASE2 This study is aimed to assess whether the frequency of meningococcal serogr...
Show More Location
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine
Learn More & Join Trial